Integra Lifesciences Holdings (IART) Non-Current Assets (2009 - 2026)
Integra Lifesciences Holdings (IART) posted Non-Current Assets of $2.4 billion for Q2 2026, down 1.4% sequentially from $2.4 billion in Q1 2026, and down 6.06% YoY from $2.5 billion in Q2 2025.
Integra Lifesciences Holdings (IART) Non-Current Assets (2009 - 2026) Analysis & Trends
Integra Lifesciences Holdings has reported Non-Current Assets for 18 years, with the latest figure at $2.4 billion in Q2 2026.
- Quarterly Non-Current Assets fell 6.06% year-over-year to $2.4 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $9.7 billion (down 14.65% YoY) and the FY2025 annual result came in at $2.4 billion, down 17.37% from the prior year.
- Non-Current Assets fell to $2.4 billion in Q2 2026 per IART's latest filing, from $2.4 billion in the prior quarter.
- Over five years, Non-Current Assets peaked at $3.0 billion in Q3 2024 and troughed at $2.4 billion in Q2 2026.
- A 5-year average of $2.7 billion and a median of $2.7 billion in 2023 frame the typical range for Non-Current Assets.
- The sharpest annual moves came in 2025 and 2026: Non-Current Assets rose 10.63% in 2025, then declined 18.33% in 2026.
- Over 5 years, Non-Current Assets stood at $2.7 billion in 2022, then declined by 0.16% to $2.7 billion in 2023, then grew by 8.51% to $3.0 billion in 2024, then fell by 17.37% to $2.4 billion in 2025, then dropped by 2.88% to $2.4 billion in 2026.
- According to Business Quant data, Non-Current Assets over the past three periods registered $2.4 billion, $2.4 billion, and $2.4 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 84.70 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 33.51 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 37.24 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 7.05 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 2.37 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 26.75 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 20.19 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 8.29 Bn |
| 10 | Integra Lifesciences Holdings | 1.28 Bn | 1.01 Bn | 219.74 Mn | 2.37 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.37 Bn |
| Mar 31, 2026 | 2.41 Bn |
| Dec 31, 2025 | 2.44 Bn |
| Sep 30, 2025 | 2.50 Bn |
| Jun 30, 2025 | 2.53 Bn |
| Mar 31, 2025 | 2.95 Bn |
| Dec 31, 2024 | 2.96 Bn |
| Sep 30, 2024 | 2.97 Bn |
| Jun 30, 2024 | 2.96 Bn |
| Mar 31, 2024 | 2.66 Bn |
| Dec 31, 2023 | 2.72 Bn |
| Sep 30, 2023 | 2.71 Bn |
| Jun 30, 2023 | 2.73 Bn |
| Mar 31, 2023 | 2.71 Bn |
| Dec 31, 2022 | 2.73 Bn |
| Sep 30, 2022 | 2.61 Bn |
| Jun 30, 2022 | 2.62 Bn |
| Mar 31, 2022 | 2.61 Bn |
| Dec 31, 2021 | 2.63 Bn |
| Sep 30, 2021 | 2.67 Bn |